New platform to help Indian pharma co's to follow international standards

Being prepared for any inspection is a priority for the Indian Pharmaceutical Industry, says industry expert The Dollar Business Bureau

PVlndia, offers platform for Indian pharma co.’s to discuss key challenges with regard to drug safety

TAKE Solutions, one of leading global technology solutions and service providers of Life Sciences, on Tuesday, announced its peer network meet called PVIndia. PVIndia is a unique pharmacovigilance network managed by Navitas, a Life Sciences division of TAKE. PVlndia network is solely based on memberships connecting the emerging global and Indian pharma companies. These companies get together to understand and share the industry's key challenges regarding drug safety. An official release of Life Sciences said, the meet was organized for companies to understand the global requirement of regulations, the ways in which companies adapted to a sleuth of international regulations and inspections. The meet was attended by 25 drug safety professionals from 14 Indian and global pharma companies. “At times when Indian companies like their colleagues in the US and EU are frequented by inspectors of internal health authorities, there exists significant strain on any organization. Being prepared for any inspection is a priority for the Indian Pharmaceutical Industry in such scenarios. PVlndia will help companies to prepare for inspections triggered by these regulations," said K. Bangarurajan, Deputy Drugs Controller of the CDSCO West. Meanwhile, Ram Yeleswarapu, President Et CEO, TAKE Solution, expressed hope that PVIndia, as an active think tank would improve drug safety and help the Indian pharma players to meet several challenges. It is noteworthy that Indian pharma companies have been under a lot of scrutiny facing hurdles with regard to drug safety from leading agencies like the United States Food and Drug Administration (USFDA). According to reports, around seven Indian companies have reportedly come under the scanner of the US regulator after having failed to maintain the required infrastructure at their local facilities. There are many such cases where Indian drug makers had to face the ire of drug inspectors. In this regard, the formation of PVIndia kind of peer networks connecting Indian drug companies to the global firms may add the needed regulatory awareness to Indian firms, that fail to comply with global standards.

March 08, 2016 | 04:39pm IST.

Related Topics:

The Dollar Business Bureau - Mar 08, 2016 11:06 IST

New platform to help Indian pharma co's to follow international standards

We like you just the way you are.